Journal of Headache and Pain

Papers
(The median citation count of Journal of Headache and Pain is 21. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Two-year effectiveness of erenumab in resistant chronic migraine: a prospective real-world analysis142
CGRP-dependent sensitization of PKC-δ positive neurons in central amygdala mediates chronic migraine116
Using natural language processing to automatically classify written self-reported narratives by patients with migraine or cluster headache88
Premonitory symptoms in migraine: a systematic review and meta-analysis of observational studies reporting prevalence or relative frequency82
Predictors of response to anti-CGRP monoclonal antibodies: a 24-week, multicenter, prospective study on 864 migraine patients67
Pre-pregnancy migraine diagnosis, medication use, and spontaneous abortion: a prospective cohort study64
Trigeminal ganglion itself can be a viable target to manage trigeminal neuralgia51
Dopamine receptor D2 regulates GLUA1-containing AMPA receptor trafficking and central sensitization through the PI3K signaling pathway in a male rat model of chronic migraine49
Similarities and differences between SUNCT and SUNA: a cross-sectional, multicentre study of 76 patients in China48
Measuring interictal burden among people affected by migraine: a descriptive survey study46
Debate: Are cluster headache and migraine distinct headache disorders?40
Swiss QUality of life and healthcare impact Assessment in a Real-world Erenumab treated migraine population (SQUARE study): interim results37
Total tenderness score and pressure pain thresholds in persistent post-traumatic headache attributed to mild traumatic brain injury36
A phase 3, randomised, placebo-controlled study of erenumab for the prevention of chronic migraine in patients from Asia: the DRAGON study35
Migraine epidemiology and comorbidities in Southern Israel: a clinical database study in a universal health coverage setting35
HMGB1 in the mPFC governs comorbid anxiety in neuropathic pain35
Development and validation of a novel model for characterizing migraine outcomes within real-world data31
Tracking the evolution of non-headache symptoms through the migraine attack31
Cerebral blood flow alterations in migraine patients with and without aura: An arterial spin labeling study31
Correction: Burden of tension-type headache in the Middle East and North Africa region, 1990-201930
Microvascular decompression in trigeminal neuralgia - a prospective study of 115 patients29
Increased risk of all-cause, Alzheimer’s, and vascular dementia in adults with migraine in Korea: a population-based cohort study29
Headache-related circuits and high frequencies evaluated by EEG, MRI, PET as potential biomarkers to differentiate chronic and episodic migraine: Evidence from a systematic review28
Efficacy and safety of monoclonal antibody against calcitonin gene-related peptide or its receptor for migraine patients with prior preventive treatment failure: a network meta-analysis28
Erenumab versus topiramate: post hoc efficacy analysis from the HER-MES study27
Longitudinal changes in functional connectivity and pain-induced brain activations in patients with migraine: a functional MRI study pre- and post- treatment with Erenumab27
Variability in recurrence rates with acute treatments for migraine: why recurrence is not an appropriate outcome measure27
Cardiac cephalalgia: a narrative review and ICHD-3 criteria evaluation27
Correction: Applying a biopsychosocial model to migraine: rationale and clinical implications26
CGRP-induced migraine-like headache in persistent post-traumatic headache attributed to mild traumatic brain injury26
Long COVID headache26
Long term evaluation of a multidisciplinary trigeminal neuralgia service25
The prevalence of primary headache disorders in children and adolescents in Zambia: a schools-based study24
Correction: A study to investigate the prevalence of headache disorders and migraine among people registered in a health insurance association in Japan21
Correction: Swiss QUality of life and healthcare impact Assessment in a Real-world Erenumab treated migraine population (SQUARE study): interim results21
Cortical spreading depression can be triggered by sensory stimulation in primed wild type mouse brain: a mechanistic insight to migraine aura generation21
Effects of eptinezumab on self-reported work productivity in adults with migraine and prior preventive treatment failure in the randomized, double-blind, placebo-controlled DELIVER study21
1.0387790203094